thecherrycreeknews.com
Feds sponsor development of drug for hospitalized influenza patients
With unique ‘mechanism of action,’ drug could become first in new class of influenza antivirals Development of an experimental influenza antiviral drug that may be more potent and could have a longer treatment window than existing drugs will receive support from the U.S.